These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 32404932)

  • 1. Enhanced alcoholic liver disease in mice with intestine-specific farnesoid X receptor deficiency.
    Huang M; Kong B; Zhang M; Rizzolo D; Armstrong LE; Schumacher JD; Chow MD; Lee YH; Joseph LB; Stofan M; Zhang L; Guo GL
    Lab Invest; 2020 Sep; 100(9):1158-1168. PubMed ID: 32404932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effects of farnesoid X receptor (FXR) on hepatic lipid accumulation are mediated by hepatic FXR and independent of intestinal FGF15 signal.
    Schmitt J; Kong B; Stieger B; Tschopp O; Schultze SM; Rau M; Weber A; Müllhaupt B; Guo GL; Geier A
    Liver Int; 2015 Apr; 35(4):1133-1144. PubMed ID: 25156247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of the intestinal bile acid/farnesoid X receptor/fibroblast growth factor 15 axis improves alcoholic liver disease in mice.
    Hartmann P; Hochrath K; Horvath A; Chen P; Seebauer CT; Llorente C; Wang L; Alnouti Y; Fouts DE; Stärkel P; Loomba R; Coulter S; Liddle C; Yu RT; Ling L; Rossi SJ; DePaoli AM; Downes M; Evans RM; Brenner DA; Schnabl B
    Hepatology; 2018 Jun; 67(6):2150-2166. PubMed ID: 29159825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FXR deficiency alters bile acid pool composition and exacerbates chronic alcohol induced liver injury.
    Kong B; Zhang M; Huang M; Rizzolo D; Armstrong LE; Schumacher JD; Chow MD; Lee YH; Guo GL
    Dig Liver Dis; 2019 Apr; 51(4):570-576. PubMed ID: 30803859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defective FXR-FGF15 signaling and bile acid homeostasis in cystic fibrosis mice can be restored by the laxative polyethylene glycol.
    Bertolini A; van de Peppel IP; Doktorova-Demmin M; Bodewes FAJA; de Jonge H; Bijvelds M; Verkade HJ; Jonker JW
    Am J Physiol Gastrointest Liver Physiol; 2019 Mar; 316(3):G404-G411. PubMed ID: 30653340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Excessive bile acid activated NF-kappa B and promoted the development of alcoholic steatohepatitis in farnesoid X receptor deficient mice.
    Wu WB; Chen YY; Zhu B; Peng XM; Zhang SW; Zhou ML
    Biochimie; 2015 Aug; 115():86-92. PubMed ID: 26025474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intestinal farnesoid X receptor signaling controls hepatic fatty acid oxidation.
    Lu D; Liu Y; Luo Y; Zhao J; Feng C; Xue L; Xu J; Wang Q; Yan T; Xiao P; Krausz KW; Gonzalez FJ; Xie C
    Biochim Biophys Acta Mol Cell Biol Lipids; 2022 Feb; 1867(2):159089. PubMed ID: 34856412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective activation of nuclear bile acid receptor FXR in the intestine protects mice against cholestasis.
    Modica S; Petruzzelli M; Bellafante E; Murzilli S; Salvatore L; Celli N; Di Tullio G; Palasciano G; Moustafa T; Halilbasic E; Trauner M; Moschetta A
    Gastroenterology; 2012 Feb; 142(2):355-65.e1-4. PubMed ID: 22057115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intestinal FXR-mediated FGF15 production contributes to diurnal control of hepatic bile acid synthesis in mice.
    Stroeve JH; Brufau G; Stellaard F; Gonzalez FJ; Staels B; Kuipers F
    Lab Invest; 2010 Oct; 90(10):1457-67. PubMed ID: 20531290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine.
    Kim I; Ahn SH; Inagaki T; Choi M; Ito S; Guo GL; Kliewer SA; Gonzalez FJ
    J Lipid Res; 2007 Dec; 48(12):2664-72. PubMed ID: 17720959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postprandial FGF19-induced phosphorylation by Src is critical for FXR function in bile acid homeostasis.
    Byun S; Kim DH; Ryerson D; Kim YC; Sun H; Kong B; Yau P; Guo G; Xu HE; Kemper B; Kemper JK
    Nat Commun; 2018 Jul; 9(1):2590. PubMed ID: 29968724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of farnesoid X receptor attenuates hepatic injury in a murine model of alcoholic liver disease.
    Wu W; Zhu B; Peng X; Zhou M; Jia D; Gu J
    Biochem Biophys Res Commun; 2014 Jan; 443(1):68-73. PubMed ID: 24269813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of spontaneous hepatocarcinogenesis in farnesoid X receptor-null mice by intestinal-specific farnesoid X receptor reactivation.
    Degirolamo C; Modica S; Vacca M; Di Tullio G; Morgano A; D'Orazio A; Kannisto K; Parini P; Moschetta A
    Hepatology; 2015 Jan; 61(1):161-70. PubMed ID: 24954587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphorylation of hepatic farnesoid X receptor by FGF19 signaling-activated Src maintains cholesterol levels and protects from atherosclerosis.
    Byun S; Jung H; Chen J; Kim YC; Kim DH; Kong B; Guo G; Kemper B; Kemper JK
    J Biol Chem; 2019 May; 294(22):8732-8744. PubMed ID: 30996006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FXR Primes the Liver for Intestinal FGF15 Signaling by Transient Induction of β-Klotho.
    Fu T; Kim YC; Byun S; Kim DH; Seok S; Suino-Powell K; Xu HE; Kemper B; Kemper JK
    Mol Endocrinol; 2016 Jan; 30(1):92-103. PubMed ID: 26505219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intestinal Farnesoid X Receptor Controls Transintestinal Cholesterol Excretion in Mice.
    de Boer JF; Schonewille M; Boesjes M; Wolters H; Bloks VW; Bos T; van Dijk TH; Jurdzinski A; Boverhof R; Wolters JC; Kuivenhoven JA; van Deursen JM; Oude Elferink RPJ; Moschetta A; Kremoser C; Verkade HJ; Kuipers F; Groen AK
    Gastroenterology; 2017 Apr; 152(5):1126-1138.e6. PubMed ID: 28065787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mouse species-specific control of hepatocarcinogenesis and metabolism by FGF19/FGF15.
    Zhou M; Luo J; Chen M; Yang H; Learned RM; DePaoli AM; Tian H; Ling L
    J Hepatol; 2017 Jun; 66(6):1182-1192. PubMed ID: 28189755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibroblast Growth Factor 21 Response in a Preclinical Alcohol Model of Acute-on-Chronic Liver Injury.
    Christidis G; Karatayli E; Hall RA; Weber SN; Reichert MC; Hohl M; Qiao S; Boehm U; Lütjohann D; Lammert F; Karatayli SC
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deficiency of Both Farnesoid X Receptor and Takeda G Protein-Coupled Receptor 5 Exacerbated Liver Fibrosis in Mice.
    Ferrell JM; Pathak P; Boehme S; Gilliland T; Chiang JYL
    Hepatology; 2019 Sep; 70(3):955-970. PubMed ID: 30664797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gender Differences in Bile Acids and Microbiota in Relationship with Gender Dissimilarity in Steatosis Induced by Diet and FXR Inactivation.
    Sheng L; Jena PK; Liu HX; Kalanetra KM; Gonzalez FJ; French SW; Krishnan VV; Mills DA; Wan YY
    Sci Rep; 2017 May; 7(1):1748. PubMed ID: 28496104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.